The	O
metastasis	B:C0949486
suppressor	I:C0949486
CD82	O
/	I:C1528437
KAI1	I:C1528437
inhibits	O
fibronectin	O
adhesion	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
by	O
repressing	O
the	O
associated	O
integrin	O
signaling	I:C1512812
.	O

The	O
metastasis	O
suppressor	I:C0949486
CD82	B:C1528437
/	I:C1528437
KAI1	I:C1528437
inhibits	O
fibronectin	O
adhesion	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
by	O
repressing	O
the	O
associated	O
integrin	O
signaling	I:C1512812
.	O

The	O
metastasis	O
suppressor	I:C0949486
CD82	O
/	I:C1528437
KAI1	I:C1528437
inhibits	O
fibronectin	B:C0016055
adhesion	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
by	O
repressing	O
the	O
associated	O
integrin	O
signaling	I:C1512812
.	O

The	O
metastasis	O
suppressor	I:C0949486
CD82	O
/	I:C1528437
KAI1	I:C1528437
inhibits	O
fibronectin	O
adhesion	B:C0007577
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
by	O
repressing	O
the	O
associated	O
integrin	O
signaling	I:C1512812
.	O

The	O
metastasis	O
suppressor	I:C0949486
CD82	O
/	I:C1528437
KAI1	I:C1528437
inhibits	O
fibronectin	O
adhesion	O
-	O
induced	O
epithelial	B:C1523298
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
by	O
repressing	O
the	O
associated	O
integrin	O
signaling	I:C1512812
.	O

The	O
metastasis	O
suppressor	I:C0949486
CD82	O
/	I:C1528437
KAI1	I:C1528437
inhibits	O
fibronectin	O
adhesion	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	B:C0033572
cancer	O
cells	I:C0334227
by	O
repressing	O
the	O
associated	O
integrin	O
signaling	I:C1512812
.	O

The	O
metastasis	O
suppressor	I:C0949486
CD82	O
/	I:C1528437
KAI1	I:C1528437
inhibits	O
fibronectin	O
adhesion	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	B:C0334227
cells	I:C0334227
by	O
repressing	O
the	O
associated	O
integrin	O
signaling	I:C1512812
.	O

The	O
metastasis	O
suppressor	I:C0949486
CD82	O
/	I:C1528437
KAI1	I:C1528437
inhibits	O
fibronectin	O
adhesion	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
by	O
repressing	O
the	O
associated	O
integrin	B:C1512812
signaling	I:C1512812
.	O

The	O
transmembrane	B:C0021699
protein	I:C0021699
CD82	O
/	I:C1528437
KAI1	I:C1528437
suppresses	O
the	O
metastatic	O
potential	O
of	O
various	O
cancer	O
cell	I:C0334227
types	O
.	O

The	O
transmembrane	O
protein	I:C0021699
CD82	B:C1528437
/	I:C1528437
KAI1	I:C1528437
suppresses	O
the	O
metastatic	O
potential	O
of	O
various	O
cancer	O
cell	I:C0334227
types	O
.	O

The	O
transmembrane	O
protein	I:C0021699
CD82	O
/	I:C1528437
KAI1	I:C1528437
suppresses	O
the	O
metastatic	O
potential	O
of	O
various	O
cancer	B:C0334227
cell	I:C0334227
types	O
.	O

Moreover	O
,	O
decrease	O
or	O
loss	O
of	O
CD82	B:C1528437
expression	O
is	O
closely	O
associated	O
with	O
malignancy	O
and	O
poor	O
prognosis	I:C0278252
in	O
many	O
human	O
cancers	O
including	O
prostate	O
cancer	I:C0376358
.	O

Moreover	O
,	O
decrease	O
or	O
loss	O
of	O
CD82	O
expression	B:C1171362
is	O
closely	O
associated	O
with	O
malignancy	O
and	O
poor	O
prognosis	I:C0278252
in	O
many	O
human	O
cancers	O
including	O
prostate	O
cancer	I:C0376358
.	O

Moreover	O
,	O
decrease	O
or	O
loss	O
of	O
CD82	O
expression	O
is	O
closely	O
associated	O
with	O
malignancy	B:C4282132
and	O
poor	O
prognosis	I:C0278252
in	O
many	O
human	O
cancers	O
including	O
prostate	O
cancer	I:C0376358
.	O

Moreover	O
,	O
decrease	O
or	O
loss	O
of	O
CD82	O
expression	O
is	O
closely	O
associated	O
with	O
malignancy	O
and	O
poor	B:C0278252
prognosis	I:C0278252
in	O
many	O
human	O
cancers	O
including	O
prostate	O
cancer	I:C0376358
.	O

Moreover	O
,	O
decrease	O
or	O
loss	O
of	O
CD82	O
expression	O
is	O
closely	O
associated	O
with	O
malignancy	O
and	O
poor	O
prognosis	I:C0278252
in	O
many	O
human	B:C0086418
cancers	O
including	O
prostate	O
cancer	I:C0376358
.	O

Moreover	O
,	O
decrease	O
or	O
loss	O
of	O
CD82	O
expression	O
is	O
closely	O
associated	O
with	O
malignancy	O
and	O
poor	O
prognosis	I:C0278252
in	O
many	O
human	O
cancers	B:C0006826
including	O
prostate	O
cancer	I:C0376358
.	O

Moreover	O
,	O
decrease	O
or	O
loss	O
of	O
CD82	O
expression	O
is	O
closely	O
associated	O
with	O
malignancy	O
and	O
poor	O
prognosis	I:C0278252
in	O
many	O
human	O
cancers	O
including	O
prostate	B:C0376358
cancer	I:C0376358
.	O

Despite	O
intense	O
scrutiny	O
,	O
the	O
mechanisms	O
underlying	O
the	O
metastasis	B:C4255448
-	O
suppressing	O
role	O
of	O
CD82	O
are	O
still	O
not	O
fully	O
understood	O
.	O

Despite	O
intense	O
scrutiny	O
,	O
the	O
mechanisms	O
underlying	O
the	O
metastasis	O
-	O
suppressing	O
role	O
of	O
CD82	B:C1528437
are	O
still	O
not	O
fully	O
understood	O
.	O

Here	O
,	O
we	O
found	O
that	O
a	O
fibronectin	B:C0016055
matrix	O
induced	O
mesenchymal	O
phenotypes	O
in	O
human	O
prostate	O
cancer	O
cells	I:C0334227
with	O
no	O
or	O
low	O
CD82	O
expression	O
levels	O
.	O

Here	O
,	O
we	O
found	O
that	O
a	O
fibronectin	O
matrix	B:C0015350
induced	O
mesenchymal	O
phenotypes	O
in	O
human	O
prostate	O
cancer	O
cells	I:C0334227
with	O
no	O
or	O
low	O
CD82	O
expression	O
levels	O
.	O

Here	O
,	O
we	O
found	O
that	O
a	O
fibronectin	O
matrix	O
induced	O
mesenchymal	O
phenotypes	O
in	O
human	B:C0086418
prostate	O
cancer	O
cells	I:C0334227
with	O
no	O
or	O
low	O
CD82	O
expression	O
levels	O
.	O

Here	O
,	O
we	O
found	O
that	O
a	O
fibronectin	O
matrix	O
induced	O
mesenchymal	O
phenotypes	O
in	O
human	O
prostate	B:C0033572
cancer	O
cells	I:C0334227
with	O
no	O
or	O
low	O
CD82	O
expression	O
levels	O
.	O

Here	O
,	O
we	O
found	O
that	O
a	O
fibronectin	O
matrix	O
induced	O
mesenchymal	O
phenotypes	O
in	O
human	O
prostate	O
cancer	B:C0334227
cells	I:C0334227
with	O
no	O
or	O
low	O
CD82	O
expression	O
levels	O
.	O

Here	O
,	O
we	O
found	O
that	O
a	O
fibronectin	O
matrix	O
induced	O
mesenchymal	O
phenotypes	O
in	O
human	O
prostate	O
cancer	O
cells	I:C0334227
with	O
no	O
or	O
low	O
CD82	B:C1528437
expression	O
levels	O
.	O

Here	O
,	O
we	O
found	O
that	O
a	O
fibronectin	O
matrix	O
induced	O
mesenchymal	O
phenotypes	O
in	O
human	O
prostate	O
cancer	O
cells	I:C0334227
with	O
no	O
or	O
low	O
CD82	O
expression	B:C1171362
levels	O
.	O

However	O
,	O
high	O
CD82	B:C1528437
expression	O
rendered	O
prostate	O
cancer	O
cells	I:C0334227
to	O
have	O
intensified	O
epithelial	O
characteristics	O
upon	O
fibronectin	O
engagement	O
,	O
along	O
with	O
decreased	O
cell	O
motility	I:C0007608
and	O
invasiveness	O
.	O

However	O
,	O
high	O
CD82	O
expression	B:C1171362
rendered	O
prostate	O
cancer	O
cells	I:C0334227
to	O
have	O
intensified	O
epithelial	O
characteristics	O
upon	O
fibronectin	O
engagement	O
,	O
along	O
with	O
decreased	O
cell	O
motility	I:C0007608
and	O
invasiveness	O
.	O

However	O
,	O
high	O
CD82	O
expression	O
rendered	O
prostate	B:C0033572
cancer	O
cells	I:C0334227
to	O
have	O
intensified	O
epithelial	O
characteristics	O
upon	O
fibronectin	O
engagement	O
,	O
along	O
with	O
decreased	O
cell	O
motility	I:C0007608
and	O
invasiveness	O
.	O

However	O
,	O
high	O
CD82	O
expression	O
rendered	O
prostate	O
cancer	B:C0334227
cells	I:C0334227
to	O
have	O
intensified	O
epithelial	O
characteristics	O
upon	O
fibronectin	O
engagement	O
,	O
along	O
with	O
decreased	O
cell	O
motility	I:C0007608
and	O
invasiveness	O
.	O

However	O
,	O
high	O
CD82	O
expression	O
rendered	O
prostate	O
cancer	O
cells	I:C0334227
to	O
have	O
intensified	O
epithelial	O
characteristics	O
upon	O
fibronectin	B:C0016055
engagement	O
,	O
along	O
with	O
decreased	O
cell	O
motility	I:C0007608
and	O
invasiveness	O
.	O

However	O
,	O
high	O
CD82	O
expression	O
rendered	O
prostate	O
cancer	O
cells	I:C0334227
to	O
have	O
intensified	O
epithelial	O
characteristics	O
upon	O
fibronectin	O
engagement	O
,	O
along	O
with	O
decreased	O
cell	B:C0007608
motility	I:C0007608
and	O
invasiveness	O
.	O

The	O
CD82	B:C1528437
function	O
of	O
inhibiting	O
fibronectin	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
was	O
dependent	O
not	O
only	O
on	O
CD82	O
interactions	O
with	O
fibronectin	O
-	O
binding	O
α3β1	O
/	O
α5β1	O
integrins	I:C1138422
but	O
also	O
on	O
the	O
integrin	O
-	I:C1155451
mediated	I:C1155451
intracellular	I:C1155451
signaling	I:C1155451
events	O
.	O

The	O
CD82	O
function	O
of	O
inhibiting	O
fibronectin	B:C0016055
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
was	O
dependent	O
not	O
only	O
on	O
CD82	O
interactions	O
with	O
fibronectin	O
-	O
binding	O
α3β1	O
/	O
α5β1	O
integrins	I:C1138422
but	O
also	O
on	O
the	O
integrin	O
-	I:C1155451
mediated	I:C1155451
intracellular	I:C1155451
signaling	I:C1155451
events	O
.	O

The	O
CD82	O
function	O
of	O
inhibiting	O
fibronectin	O
-	O
induced	O
epithelial	B:C1523298
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
was	O
dependent	O
not	O
only	O
on	O
CD82	O
interactions	O
with	O
fibronectin	O
-	O
binding	O
α3β1	O
/	O
α5β1	O
integrins	I:C1138422
but	O
also	O
on	O
the	O
integrin	O
-	I:C1155451
mediated	I:C1155451
intracellular	I:C1155451
signaling	I:C1155451
events	O
.	O

The	O
CD82	O
function	O
of	O
inhibiting	O
fibronectin	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	B:C1523298
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
was	O
dependent	O
not	O
only	O
on	O
CD82	O
interactions	O
with	O
fibronectin	O
-	O
binding	O
α3β1	O
/	O
α5β1	O
integrins	I:C1138422
but	O
also	O
on	O
the	O
integrin	O
-	I:C1155451
mediated	I:C1155451
intracellular	I:C1155451
signaling	I:C1155451
events	O
.	O

The	O
CD82	O
function	O
of	O
inhibiting	O
fibronectin	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
was	O
dependent	O
not	O
only	O
on	O
CD82	B:C1528437
interactions	O
with	O
fibronectin	O
-	O
binding	O
α3β1	O
/	O
α5β1	O
integrins	I:C1138422
but	O
also	O
on	O
the	O
integrin	O
-	I:C1155451
mediated	I:C1155451
intracellular	I:C1155451
signaling	I:C1155451
events	O
.	O

The	O
CD82	O
function	O
of	O
inhibiting	O
fibronectin	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
was	O
dependent	O
not	O
only	O
on	O
CD82	O
interactions	B:C0872079
with	O
fibronectin	O
-	O
binding	O
α3β1	O
/	O
α5β1	O
integrins	I:C1138422
but	O
also	O
on	O
the	O
integrin	O
-	I:C1155451
mediated	I:C1155451
intracellular	I:C1155451
signaling	I:C1155451
events	O
.	O

The	O
CD82	O
function	O
of	O
inhibiting	O
fibronectin	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
was	O
dependent	O
not	O
only	O
on	O
CD82	O
interactions	O
with	O
fibronectin	B:C0016055
-	O
binding	O
α3β1	O
/	O
α5β1	O
integrins	I:C1138422
but	O
also	O
on	O
the	O
integrin	O
-	I:C1155451
mediated	I:C1155451
intracellular	I:C1155451
signaling	I:C1155451
events	O
.	O

The	O
CD82	O
function	O
of	O
inhibiting	O
fibronectin	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
was	O
dependent	O
not	O
only	O
on	O
CD82	O
interactions	O
with	O
fibronectin	O
-	O
binding	B:C0033618
α3β1	O
/	O
α5β1	O
integrins	I:C1138422
but	O
also	O
on	O
the	O
integrin	O
-	I:C1155451
mediated	I:C1155451
intracellular	I:C1155451
signaling	I:C1155451
events	O
.	O

The	O
CD82	O
function	O
of	O
inhibiting	O
fibronectin	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
was	O
dependent	O
not	O
only	O
on	O
CD82	O
interactions	O
with	O
fibronectin	O
-	O
binding	O
α3β1	B:C0246766
/	O
α5β1	O
integrins	I:C1138422
but	O
also	O
on	O
the	O
integrin	O
-	I:C1155451
mediated	I:C1155451
intracellular	I:C1155451
signaling	I:C1155451
events	O
.	O

The	O
CD82	O
function	O
of	O
inhibiting	O
fibronectin	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
was	O
dependent	O
not	O
only	O
on	O
CD82	O
interactions	O
with	O
fibronectin	O
-	O
binding	O
α3β1	O
/	O
α5β1	B:C1138422
integrins	I:C1138422
but	O
also	O
on	O
the	O
integrin	O
-	I:C1155451
mediated	I:C1155451
intracellular	I:C1155451
signaling	I:C1155451
events	O
.	O

The	O
CD82	O
function	O
of	O
inhibiting	O
fibronectin	O
-	O
induced	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
(	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
)	O
was	O
dependent	O
not	O
only	O
on	O
CD82	O
interactions	O
with	O
fibronectin	O
-	O
binding	O
α3β1	O
/	O
α5β1	O
integrins	I:C1138422
but	O
also	O
on	O
the	O
integrin	B:C1155451
-	I:C1155451
mediated	I:C1155451
intracellular	I:C1155451
signaling	I:C1155451
events	O
.	O

Notably	O
,	O
CD82	B:C1528437
attenuated	O
the	O
FAK	O
-	I:C1148560
Src	I:C1148560
and	O
ILK	O
pathways	I:C1148560
downstream	O
of	O
the	O
fibronectin	O
-	O
receptor	O
integrins	I:C0021701
.	O

Notably	O
,	O
CD82	O
attenuated	O
the	O
FAK	B:C1148560
-	I:C1148560
Src	I:C1148560
and	O
ILK	O
pathways	I:C1148560
downstream	O
of	O
the	O
fibronectin	O
-	O
receptor	O
integrins	I:C0021701
.	O

Notably	O
,	O
CD82	O
attenuated	O
the	O
FAK	O
-	I:C1148560
Src	I:C1148560
and	O
ILK	B:C1148560
pathways	I:C1148560
downstream	O
of	O
the	O
fibronectin	O
-	O
receptor	O
integrins	I:C0021701
.	O

Notably	O
,	O
CD82	O
attenuated	O
the	O
FAK	O
-	I:C1148560
Src	I:C1148560
and	O
ILK	O
pathways	I:C1148560
downstream	B:C0522506
of	O
the	O
fibronectin	O
-	O
receptor	O
integrins	I:C0021701
.	O

Notably	O
,	O
CD82	O
attenuated	O
the	O
FAK	O
-	I:C1148560
Src	I:C1148560
and	O
ILK	O
pathways	I:C1148560
downstream	O
of	O
the	O
fibronectin	B:C0016055
-	O
receptor	O
integrins	I:C0021701
.	O

Notably	O
,	O
CD82	O
attenuated	O
the	O
FAK	O
-	I:C1148560
Src	I:C1148560
and	O
ILK	O
pathways	I:C1148560
downstream	O
of	O
the	O
fibronectin	O
-	O
receptor	B:C0021701
integrins	I:C0021701
.	O

Immunofluorescence	B:C0079603
staining	O
of	O
human	O
prostate	O
cancer	I:C0376358
tissue	O
specimens	I:C1292533
illustrated	O
a	O
negative	O
association	O
of	O
CD82	O
with	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
-	O
related	O
gene	O
expression	I:C0017262
as	O
well	O
as	O
prostate	O
malignancy	O
.	O

Immunofluorescence	O
staining	B:C0487602
of	O
human	O
prostate	O
cancer	I:C0376358
tissue	O
specimens	I:C1292533
illustrated	O
a	O
negative	O
association	O
of	O
CD82	O
with	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
-	O
related	O
gene	O
expression	I:C0017262
as	O
well	O
as	O
prostate	O
malignancy	O
.	O

Immunofluorescence	O
staining	O
of	O
human	B:C0086418
prostate	O
cancer	I:C0376358
tissue	O
specimens	I:C1292533
illustrated	O
a	O
negative	O
association	O
of	O
CD82	O
with	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
-	O
related	O
gene	O
expression	I:C0017262
as	O
well	O
as	O
prostate	O
malignancy	O
.	O

Immunofluorescence	O
staining	O
of	O
human	O
prostate	B:C0376358
cancer	I:C0376358
tissue	O
specimens	I:C1292533
illustrated	O
a	O
negative	O
association	O
of	O
CD82	O
with	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
-	O
related	O
gene	O
expression	I:C0017262
as	O
well	O
as	O
prostate	O
malignancy	O
.	O

Immunofluorescence	O
staining	O
of	O
human	O
prostate	O
cancer	I:C0376358
tissue	B:C1292533
specimens	I:C1292533
illustrated	O
a	O
negative	O
association	O
of	O
CD82	O
with	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
-	O
related	O
gene	O
expression	I:C0017262
as	O
well	O
as	O
prostate	O
malignancy	O
.	O

Immunofluorescence	O
staining	O
of	O
human	O
prostate	O
cancer	I:C0376358
tissue	O
specimens	I:C1292533
illustrated	O
a	O
negative	B:C0205160
association	O
of	O
CD82	O
with	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
-	O
related	O
gene	O
expression	I:C0017262
as	O
well	O
as	O
prostate	O
malignancy	O
.	O

Immunofluorescence	O
staining	O
of	O
human	O
prostate	O
cancer	I:C0376358
tissue	O
specimens	I:C1292533
illustrated	O
a	O
negative	O
association	O
of	O
CD82	B:C1528437
with	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
-	O
related	O
gene	O
expression	I:C0017262
as	O
well	O
as	O
prostate	O
malignancy	O
.	O

Immunofluorescence	O
staining	O
of	O
human	O
prostate	O
cancer	I:C0376358
tissue	O
specimens	I:C1292533
illustrated	O
a	O
negative	O
association	O
of	O
CD82	O
with	O
epithelial	B:C1523298
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
-	O
related	O
gene	O
expression	I:C0017262
as	O
well	O
as	O
prostate	O
malignancy	O
.	O

Immunofluorescence	O
staining	O
of	O
human	O
prostate	O
cancer	I:C0376358
tissue	O
specimens	I:C1292533
illustrated	O
a	O
negative	O
association	O
of	O
CD82	O
with	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
-	O
related	O
gene	B:C0017262
expression	I:C0017262
as	O
well	O
as	O
prostate	O
malignancy	O
.	O

Immunofluorescence	O
staining	O
of	O
human	O
prostate	O
cancer	I:C0376358
tissue	O
specimens	I:C1292533
illustrated	O
a	O
negative	O
association	O
of	O
CD82	O
with	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
-	O
related	O
gene	O
expression	I:C0017262
as	O
well	O
as	O
prostate	B:C0033572
malignancy	O
.	O

Immunofluorescence	O
staining	O
of	O
human	O
prostate	O
cancer	I:C0376358
tissue	O
specimens	I:C1292533
illustrated	O
a	O
negative	O
association	O
of	O
CD82	O
with	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
-	O
related	O
gene	O
expression	I:C0017262
as	O
well	O
as	O
prostate	O
malignancy	B:C4282132
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
CD82	B:C0812444
suppresses	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
adhered	O
to	O
the	O
fibronectin	O
matrix	O
by	O
repressing	O
adhesion	O
signaling	O
through	O
lateral	O
interactions	O
with	O
the	O
associated	O
α3β1	O
and	O
α5	O
β1	I:C1138422
integrins	I:C1138422
,	O
leading	O
to	O
reduced	O
cell	O
migration	I:C1622501
and	O
invasive	O
capacities	O
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
CD82	O
suppresses	O
epithelial	B:C1523298
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
adhered	O
to	O
the	O
fibronectin	O
matrix	O
by	O
repressing	O
adhesion	O
signaling	O
through	O
lateral	O
interactions	O
with	O
the	O
associated	O
α3β1	O
and	O
α5	O
β1	I:C1138422
integrins	I:C1138422
,	O
leading	O
to	O
reduced	O
cell	O
migration	I:C1622501
and	O
invasive	O
capacities	O
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
CD82	O
suppresses	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	B:C0033572
cancer	O
cells	I:C0334227
adhered	O
to	O
the	O
fibronectin	O
matrix	O
by	O
repressing	O
adhesion	O
signaling	O
through	O
lateral	O
interactions	O
with	O
the	O
associated	O
α3β1	O
and	O
α5	O
β1	I:C1138422
integrins	I:C1138422
,	O
leading	O
to	O
reduced	O
cell	O
migration	I:C1622501
and	O
invasive	O
capacities	O
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
CD82	O
suppresses	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	B:C0334227
cells	I:C0334227
adhered	O
to	O
the	O
fibronectin	O
matrix	O
by	O
repressing	O
adhesion	O
signaling	O
through	O
lateral	O
interactions	O
with	O
the	O
associated	O
α3β1	O
and	O
α5	O
β1	I:C1138422
integrins	I:C1138422
,	O
leading	O
to	O
reduced	O
cell	O
migration	I:C1622501
and	O
invasive	O
capacities	O
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
CD82	O
suppresses	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
adhered	O
to	O
the	O
fibronectin	B:C0016055
matrix	O
by	O
repressing	O
adhesion	O
signaling	O
through	O
lateral	O
interactions	O
with	O
the	O
associated	O
α3β1	O
and	O
α5	O
β1	I:C1138422
integrins	I:C1138422
,	O
leading	O
to	O
reduced	O
cell	O
migration	I:C1622501
and	O
invasive	O
capacities	O
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
CD82	O
suppresses	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
adhered	O
to	O
the	O
fibronectin	O
matrix	B:C0015350
by	O
repressing	O
adhesion	O
signaling	O
through	O
lateral	O
interactions	O
with	O
the	O
associated	O
α3β1	O
and	O
α5	O
β1	I:C1138422
integrins	I:C1138422
,	O
leading	O
to	O
reduced	O
cell	O
migration	I:C1622501
and	O
invasive	O
capacities	O
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
CD82	O
suppresses	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
adhered	O
to	O
the	O
fibronectin	O
matrix	O
by	O
repressing	O
adhesion	O
signaling	O
through	O
lateral	B:C0205093
interactions	O
with	O
the	O
associated	O
α3β1	O
and	O
α5	O
β1	I:C1138422
integrins	I:C1138422
,	O
leading	O
to	O
reduced	O
cell	O
migration	I:C1622501
and	O
invasive	O
capacities	O
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
CD82	O
suppresses	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
adhered	O
to	O
the	O
fibronectin	O
matrix	O
by	O
repressing	O
adhesion	O
signaling	O
through	O
lateral	O
interactions	O
with	O
the	O
associated	O
α3β1	B:C0246766
and	O
α5	O
β1	I:C1138422
integrins	I:C1138422
,	O
leading	O
to	O
reduced	O
cell	O
migration	I:C1622501
and	O
invasive	O
capacities	O
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
CD82	O
suppresses	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
adhered	O
to	O
the	O
fibronectin	O
matrix	O
by	O
repressing	O
adhesion	O
signaling	O
through	O
lateral	O
interactions	O
with	O
the	O
associated	O
α3β1	O
and	O
α5	B:C1138422
β1	I:C1138422
integrins	I:C1138422
,	O
leading	O
to	O
reduced	O
cell	O
migration	I:C1622501
and	O
invasive	O
capacities	O
.	O

Altogether	O
,	O
these	O
results	O
suggest	O
that	O
CD82	O
suppresses	O
epithelial	O
-	I:C1523298
to	I:C1523298
-	I:C1523298
mesenchymal	I:C1523298
transition	I:C1523298
in	O
prostate	O
cancer	O
cells	I:C0334227
adhered	O
to	O
the	O
fibronectin	O
matrix	O
by	O
repressing	O
adhesion	O
signaling	O
through	O
lateral	O
interactions	O
with	O
the	O
associated	O
α3β1	O
and	O
α5	O
β1	I:C1138422
integrins	I:C1138422
,	O
leading	O
to	O
reduced	O
cell	B:C1622501
migration	I:C1622501
and	O
invasive	O
capacities	O
.	O

